Breast Cancer Trials in Newcastle, New South Wales | Medical service

Breast Cancer Trials

Locality: Newcastle, New South Wales

Phone: +61 1800 423 444

Address: Level 4, 175 Scott St 2300 Newcastle, NSW, Australia

Website: http://www.breastcancertrials.org.au

Likes: 35190

Add/Update information

Reviews

Tags

• Medical and health
• Non-profit organisation
• Charitable organisation
• Medical service

25.01.2022 This week (September 7 15) is #IncludeACharityWeek. Have you considered including a Gift in your Will to Charity? It is one of the most powerful ways you can help to identify the treatments needed to save every life from breast cancer and spare every family from loss. Were proud members of @IncludeaCharity, a social change campaign aiming to encourage more people to include a charity in their Will. Gifts in Wills play such a vital part in what we can achieve. ... If you would like to talk to us about how a Gift in your Will can help countless others, please call our Special Gifts Officer Cheryl on 1800 423 444 or go to www.breastcancertrials.org.au.

24.01.2022 Join us in the Breastolution and help us to prevent breast cancer in women most at risk. The Breastolution is all about the BRCA-P clinical trial. This game-changing research is testing the effectiveness of using a drug called Denosumab to decrease or prevent the risk of developing breast cancer in women who carry a BRCA1 gene mutation.... The BRCA-P prevention clinical trial has been fast-tracked from the laboratory because of the very positive pre-clinical data seen and because a Phase III clinical trial can provide the large numbers of participants needed to find out if it is effective in the shortest timeframe. There are many ways you can support this research and help to save lives from breast cancer. Join us at breastolution.com.au

24.01.2022 Breast Cancer Trials currently has three clinical trials open to metastatic patients, including the CAPTURE clinical trial. CAPTURE is a new clinical trial which hopes to improve outcomes for women and men with ER+, HER-2 negative metastatic breast cancer with the genetic mutation PIK3CA. Oestrogen-receptor positive (ER+) breast cancers account for over 70% of all breast cancers and about 40% of these patients have a PIK3CA mutation. PIK3CA mutations are one of the most comm...only mutated genes in solid cancers and can be found by testing tumour tissue or blood. CAPTURE will use a drug called alpelisib which belongs to a class of drug called a PI3K inhibitor, together with fulvestrant, to see if these patients are more likely to benefit from this new treatment regimen. Learn more about CAPTURE here:https://www.breastcancertrials.org.au/current-clini/capture

22.01.2022 For women with a high risk of developing breast cancer, the IBIS clinical trial proved that tamoxifen reduces breast cancer rates by nearly a third. Long-term follow up of IBIS-I released in 2006, found that tamoxifen reduces the risk of hormone receptor positive breast cancer (which accounts for two thirds of all breast cancers) by 34% in women at increased risk of the disease and that the benefit continues for at least several years even after treatment with the drug has s...topped. In 2014, new extended analysis of tamoxifen showed that the preventative effect of the drug continues for 20 years. We're incredibly proud to have conducted this trial in Australia and New Zealand and recruited 2,674 patients for this important research. Learn more about this research here: https://www.breastcancertrials.org.au/ibis-i-clinical-trial

22.01.2022 Today is R U OK? Day Its a day to check in with yourself and your loved ones and ask R U OK? As many in our community would know, receiving a breast cancer diagnosis is incredibly distressing for the patient as well as their loved ones. The impact of a breast cancer diagnosis on a persons mental health is substantial and its important to look after your physical and mental health during this time. ... We spoke with clinical psychologist and Breast Cancer Trials Scientific Advisory Committee member Dr Lisa Beatty about the mental health impact of breast cancer and how you can get help. Learn more here: https://www.breastcancertrials.org.au/research-blog

21.01.2022 Celebrate being allowed back out on the green in style! Thats exactly what the members of Westward Ho Golf Club did at their Tee Off event in August. If youre a golfer, why not get your social club together to host a Tee Off event. Its a chance to add some excitement to your social calendar after the tough year weve all had. ... Plus, youll be raising money for breast cancer research that will change the future for all women at risk of breast cancer. You can easily register your event here: https://www.breastcancertrials.org.au/tee-off-for-breast-ca. Its almost October which means Breast Cancer Awareness Month is just around the corner. Its the perfect time to host your event! Were thinking of all our friends in Victoria who cant host a Tee Off event right now. We look forward to working with you again when restrictions ease.

20.01.2022 New research has found that patients with metastatic breast cancer may benefit from having their genome profiled, to help identify tumours that could be treated with a targeted treatment. Called the SEGMENT study, the aim of the proof of concept research was to examine the feasibility of characterising genomic alterations using a customized next generation multi-gene sequencing panel on tumour specimens obtained from patients with incurable and/or advanced breast cancer. The ...project received Breast Cancer Trials Discretionary Funding of $50,000 in year 1 and $50,000 in year 2, which was awarded to Professor Sherene Loi (pictured) from the Peter MacCallum Cancer Centre. Learn more: https://www.breastcancertrials.org.au/news?id=517

20.01.2022 The PATINA clinical trial is investigating if the addition of the drug palbociclib, can lengthen the time breast cancer can be controlled and prolong survival for people with HER2-positive metastatic breast cancer. Learn more about PATINA here: https://www.breastcancertrials.org.au/current-clinic/patina

20.01.2022 Breast Cancer Trials is at the forefront of breast cancer research in Australia and New Zealand. If you'd like to be kept in the loop about our research, join IMPACT. You'll get the latest news about breast cancer clinical trials research in your inbox and can find out more about how you can be an advocate for clinical trials research in your community. Join here: https://www.breastcancertrials.org.au/join-impact

19.01.2022 Sherri is a participant in the POSNOC clinical trial and says the support she has received on the trial has been brilliant. POSNOC is looking at whether we can identify women, whose breast cancer has spread to one or two lymph nodes, who may be able to avoid the removal of all axillary nodes or radiotherapy to the armpit and thereby the potential side effects of treatment such as lymphoedema. Learn more about POSNOC here: https://www.breastcancertrials.org.au/current-clinic/posnoc

18.01.2022 It's Women's Health Week. Women's Health Week is a time to stop and learn more about your health and well being, and see if there are any changes you can make to your lifestyle. Currently, there is no way to definitively prevent breast cancer from occurring. However, there are ways to manage some breast cancer risk factors to reduce the likelihood of future breast cancer. Over the course of your lifetime there are a number of risk factors you may be exposed to. Some cannot ...be changed, such as being a woman or having a strong family history, however other factors can be changed through healthy lifestyle decisions and risk-reducing strategies. Learn more here: https://www.breastcancertrials.org.au/research-blog

17.01.2022 We are very excited to announce that our researchers have recruited the first patient to the Breast MRI Evaluation Study. The Australian Federal Government recently funded MRI via the Medical Benefits Schedule (MBS) to be used in some women with early breast cancer. Under the MBS, MRI can be used where there is a difference between a physical examination of the breast by a doctor (clinical examination) compared to imaging examinations (such as ultrasounds or mammograms) and /...or the results of the MRI may change the type of treatment originally planned. However, this is temporary funding and the Government has asked for more research to find out the best way to use MRI, when it will be most useful, and to find out if it can improve treatment options and patient outcomes. As part of this research request, this study will help us find out if having a breast MRI after being diagnosed with breast cancer might change plans for treatment and how this might affect patient outcomes. The Breast MRI Evaluation Study is open at five sites across WA, NSW and VIC. Two more sites will be open in the future. Learn More: https://www.breastcancertrials.org.au/c/breastevaluationmri

15.01.2022 Our 3 Course Challenge has been non-stop fun and excitement. Most importantly, our 3 Course Challengers raised $133,500! These vital funds will help continue research that is the proven pathway to saving every life from breast cancer. Thank you to our amazing fundraisers whove blown us away by their incredible dedication to raising money for our research. ... Our 188 amazing chefs bravely took on the challenge of cooking a three course French meal for their friends and family and each hosted a magnifique dinner party. Were so grateful to all the friends, family members and colleagues of our challengers who supported them by donating and attending their dinner parties (and helping with the washing up!) Wed also like to thank our amazing host Manu Feildel who generously donated his time to the challenge. Manu specially curated the menu for our challengers and taught them all the cook the delicious meals in a livestreamed cooking class. Were so grateful to have such a kind and generous community by our side. Together, we can help stop the impact this horrible disease has on our lives. Stay tuned for whats next.

14.01.2022 Triple negative breast cancer can be more aggressive and difficult type of breast cancer to treat. Our researchers are working on finding new and better treatments for this breast cancer type, including the Neo-N clinical trial. Neo-N is investigating if using the immunotherapy drug nivolumab, together with standard chemotherapy, is a safe and effective way of treating early triple negative breast cancer before surgery. Learn more about Neo-N here: https://www.breastcancertrials.org.au/current-clinical/neon

13.01.2022 For the third year in a row, Breast Cancer Trials researcher Professor Sherene Loi has been included in the worldwide Web of Science Highly Cited Researchers list in the category of Clinical Medicine. This highly prestigious list identifies the top scientists and researchers from around the world who produced multiple papers ranking in the top 1% by citations for their field and year of publication. This demonstrates significant research influence among their peers. Professor... Loi is very active in the Breast Cancer Trials research program. She is the Study Chair of the DIAmOND and Neo-N clinical trial and this year was appointed to the Breast Cancer Trials Board of Directors. Congratulations to Professor Loi on this outstanding achievement and for the advances you are helping to bring to breast cancer treatments for women worldwide.

13.01.2022 I hope youll join us in congratulating Toni, our highest fundraiser in the 3 Course Challenge! Toni is no stranger to a challenge as the last few months of her life have been tough to say the least. In March, Toni was diagnosed with triple negative breast cancer. Shes been travelling a five hour round trip to receive chemotherapy every Monday, kissing goodbye to her beautiful 3 and 4 year old. ... Toni finished chemotherapy one week ago and took on the 3 Course Challenge to celebrate and give back to some of the amazing people who supported her during chemotherapy. She raised an incredible $6,000 during the challenge which we think is just amazing. Thank you Toni and all our dedicated 3 Course Challengers for your devotion to changing the future for all women at risk of breast cancer.

12.01.2022 It is with great sadness that we deliver the news of the passing of one of the founders of Breast Cancer Trials, Professor Martin Tattersall AO. Professor Tattersall played an instrumental role in the development of breast cancer clinical trials research in this region. He was one of the first participating sites in our research program in 1978 with the Ludwig Institute for Cancer Research at the Royal Prince Alfred Hospital in Sydney. He was a member of our Scientific Adviso...ry Committee from 1992 2007 and was subsequently appointed to the Independent Data and Monitoring Committee from 2008 until early 2019, which he held the position of Chair since January 2010. In 2019, he received the Breast Cancer Trials Gold Medal at the Annual Scientific Meeting in Adelaide (pictured below with the Chair of our Board, Professor Bruce Mann). Over his expansive career, Professor Tattersall secured approximately $20 million of research funding and was appointed Professor of Medicine at the University of Sydney in 1977. He was a member of the World Health Organisation (WHO) Cancer Committee for 20 years and he is a Life Member of the International Union Against Cancer (UICC) Roll of Honour. He was awarded the Medical Oncology Group of Australia (MOGA) Cancer Achievement Award in 2000 and chaired the Australian Drug Evaluation Committee (ADEC) from 1997-2008. He will be deeply missed by his colleagues and friends at Breast Cancer Trials, and we send our deepest sympathy to his family.

11.01.2022 Associate Professor Aleix Prat says researchers are working to make metastatic breast cancer a liveable 'chronic disease' while working towards a cure. In this Breast Cancer Trials podcast we speak about how we can predict outcomes in HR positive, HER2 negative metastatic breast cancer and how researchers are working to make metastatic disease more manageable.

11.01.2022 We bet youd look pretty in pink! Its only two weeks until October which means its nearly Breast Cancer Awareness Month and the perfect time to host a pink fundraiser. Whether its a small morning tea with friends and family, or a glamorous event with people from your community, every dollar raised will fund vital research to help save and improves the lives of people with breast cancer. ... If youre in Victoria, you could hold a virtual event such as an online raffle or silent auction. There are many fundraising initiatives you can undertake from the safety of your own home. Our Community Fundraising team would love to help make your event special, get in touch today at [email protected].

11.01.2022 Its #WomensHealthWeek2020 Did you know you're not supposed to check your breasts at the same time every month? A womans breasts can change throughout the month, due to hormones and menstrual cycle, so its important to know the look and feel of your breasts at every point in the month. It's also important to note that some breast cancers present no symptoms at all. You can learn more about self-checking and the symptoms of breast cancer here: https://www.breastcancertrials.org.au/research-blog

09.01.2022 Breast Cancer Trials is pleased to announce that our new Breast MRI Evaluation study is now open to patients. The Australian Federal Government recently funded MRI via the Medical Benefits Schedule (MBS) to be used in some women with early breast cancer. Under the MBS, MRI can be used where there is a difference between a physical examination of the breast by a doctor (clinical examination) compared to imaging examinations (such as ultrasounds or mammograms) and /or the resu...lts of the MRI may change the type of treatment originally planned. However, this is temporary funding and the Government has asked for more research to find out the best way to use MRI, when it will be most useful, and to find out if it can improve treatment options and patient outcomes. As part of this research request, this study will help us find out if having a breast MRI after being diagnosed with breast cancer might change plans for treatment and how this might affect patient outcomes. The study is now open at the Fiona Stanley Hospital and Royal Perth Hospital, with five more sites to be open soon, and we are aiming to recruit at least 400 patients to the study. Professor Christobel Saunders is the Study Chair of the Breast MRI Evaluation study. Learn more about this study here: https://www.breastcancertrials.org.au/c/breastevaluationmri

09.01.2022 Today is International Legacy Giving Day. A time when, around the world, charities acknowledge the generosity of those who choose to leave Gifts in their Will to charitable causes. Gifts in Wills play a vital role in supporting our breast cancer trials research program, helping to ensure that research continues to make advances which will impact the lives of people well into the future. ... We acknowledge the gifts we have received and which are making the research we do today possible. And we thank all the amazing people who have included Breast Cancer Trials in their Will. If changing the future for everyone at risk of breast cancer is important to you too, get in touch with our Special Gifts Officer Cheryl on 1800 423 444 for more information.

08.01.2022 The EXPERT clinical trial aims to improve personalised use of radiation therapy in patients with early breast cancer, based on their individual risk of breast cancer returning. If successful, it may mean that some patients don't need to have radiation therapy and the potential side effects of this treatment. Learn more about EXPERT here: https://www.breastcancertrials.org.au/current-clinic/expert

08.01.2022 Without clinical trial participants, there would be no new treatments or prevention strategies for breast cancer. Learn more about why you should participate in a clinical trial here: https://www.breastcancertrials.org.au/what-is-a-clinical-tr

07.01.2022 Due to COVID-19 restrictions we were not able to hold our annual Q&A event in person this year - so were taking it online! We have lined up four leading Australian breast cancer experts to talk and answer your questions on the latest in breast cancer research, the likelihood of breast cancer recurrence, the myths around breast cancer and the impact breast cancer has on mental health and how you can receive support. The panel includes Professor Fran Boyle AM, Associate Profe...ssor Prue Francis, Associate Professor Lesley Stafford and Dr Nick Zdenkowski who will present and then answer associated questions from the online audience. The Q&A will be held online at 6pm-7pm AEDT on Wednesday 7th October. This year has been an incredibly tough one, particularly for those who are being treated for breast cancer and health professionals, and this session hopes to offer a safe and useful resource for those in our community, helping to answer your breast cancer questions. To take part in this free Q&A, please register here: https://www.eventbrite.com.au/e/breast-cancer-2020-the-medi

06.01.2022 The CAPTURE clinical trial hopes to improve outcomes for women and men with ER+, HER-2 negative metastatic breast cancer with a PIK3CA mutation. CAPTURE will use a drug called alpelisib which belongs to a class of drug called a PI3K inhibitor, together with fulvestrant, to see if these patients are more likely to benefit from this new treatment regimen, more so than standard treatment. Professor Sarah-Jane Dawson is the Study Chair of the CAPTURE clinical trial. Learn more about CAPTURE here: https://www.breastcancertrials.org.au/current-clini/capture

05.01.2022 Breast Cancer Trials has been saving lives for more than 40 years. We are proud to have almost 800 researchers working across more than 100 institutions in Australia and New Zealand. Our researchers are all working towards the same goal: to save and better the lives of every person affected by breast cancer. Learn more about Breast Cancer Trials here: https://www.breastcancertrials.org.au/timeline

05.01.2022 The fear of your breast cancer coming back, is a common issue faced by women who have had early stage breast cancer. The chance of recurrence is not the same for all breast cancer patients as there is a number of factors that contribute to an individuals risk of their breast cancer returning. Professor Fran Boyle AM addressed this topic during our online live Q&A last month. She spoke about what you should be on the look out for after your initial diagnosis, how to reduce y...our risk of recurrence and the research currently taking place into metastatic breast cancer. You can catch up on her talk below and check out our research blog for more information: https://www.breastcancertrials.org.au/research-blog

05.01.2022 What a wonderful weekend for our 3 Course Challengers! It was such a pleasure to join Manu Feildel last Saturday for his livestreamed cooking lesson where he taught us all to cook a three-course French meal. Were so grateful to Manu for being so generous with his time and creating such a delicious menu! Some of our 3 Course Challengers then went off to host a French themed dinner party that very night! Others are hosting their dinner parties in the coming weeks. Dont the pi...ctures look great? This is just a snippet - there's more to come! It was lovely to hear from so many in Victoria who found this to be their most fun night in lockdown! We're so grateful to all our challengers for taking on this exciting new fundraising challenge. If you would like to learn from Manu how to have a fantastic French dinner party, like our 3 Course Challengers below, its not too late. You can join the 3 Course Challenge and raise $150 to gain access to Manus recorded cooking class, plus the recipes and menu for your dinner party as well as a lots of other goodies. www.3coursechallenge.com.au. The 3 Course Challenge has already raised an incredible $111,000! And we wont stop there, were now aiming for $115,000. So, why not register for the challenge and join the fun!

05.01.2022 Breast Cancer Trials is one of the oldest breast cancer organisations in Australia and New Zealand. Our researchers have been saving the lives of people affected by breast cancer for more than 40 years and in collaboration with our international partners, have been responsible for some of the greatest breakthroughs in breast cancer treatment and prevention in Australia and around the world. Breast Cancer Trials started as a small group of doctors (some of which are pictured... below) who wanted to improve breast cancer treatments and outcomes for everyone diagnosed with breast cancer and those at risk. When we began in 1978, the only option for women with breast cancer was a radical mastectomy, Now, more than 40 years later, Breast Cancer Trials has grown to be one of the most respected research groups in the world. We have almost 800 researchers working across more than 100 institutions in Australia and New Zealand. Our researchers are committed to improving and saving the lives of people affected by breast cancer, just like our founders were in 1978.

05.01.2022 The Neo-N Clinical trial has opened at three more sites across Australia! Neo-N is a clinical trial open to both women and men diagnosed with triple negative early breast cancer. The Neo-N clinical trial is investigating if using an immunotherapy drug alone before to the combination of immunotherapy and standard chemotherapy is safe and effective in treating triple negative breast cancer before surgery. Learn more about the Neo-N clinical trial here: https://www.breastcancertrials.org.au/current-clinical/neon

02.01.2022 Paul had a wonderful life with his wife Fran until breast cancer cruelly took her away at just 60. They had a whole life planned together that just didnt happen. Paul says breast cancer ruined his life. He made the decision to leave a Gift in his Will to Breast Cancer Trials, to help protect other families from the devastating impact breast cancer has had on his family. ... Pauls family fully support him as they know the powerful impact his gift will have. If you would like information about leaving a Gift in your Will to support research to change the future for all women at risk of breast cancer, please call our Special Gifts Office Cheryl on 1800 423 444 or visit www.breastcancertrials.org.au.

01.01.2022 New research from Western Australia has found that venom from honeybees could potentially help treat aggressive triple-negative and HER2- enriched breast cancers. The research showed a specific concentration of the venom killed 100 per cent of triple-negative breast cancer and HER2-enriched breast cancer cells within 60 minutes, while having minimal effects on normal cells. The research, which is in its very early stage and has yet to be tested in humans, could potentially help researchers develop new treatments for triple-negative breast cancers.